The other day I wrote about the challenge in addressing the pandemic—a worldwide science/engineering problem—using our existing science and engineering infrastructure, which is some mix of government labs and regulatory agencies, private mega-companies, smaller companies, university researchers, and media entities and rich people who can direct attention and resources. The current system might be the …